Background: Hypertension is known to develop atrial hypertrophy and fi brosis leading to atrial fibrillation. In the ventricle, signaling through the mammalian target of rapamycin (mTOR) pathway has emerged as an important regulator for hypertrophy. However, little is known in the atrium. Methods: Hearts of 10-weekold (10W) and 24W spontaneously hypertensive rats (SHRs; n=6 respectively) and age-matched Wister-Kyoto rats (WKYs; n=6 respectively) were subjected to Western blotting and immunohistochemistry. We examined the phosphorylation rate of mTOR and its downstream translational signaling intermediate, 70kDa ribosomal protein S6 kinase (S6K) in atria. Results: Systolic blood pressure increased significantly in SHRs versus WKYs (10W-SHRs; 165 10, 10W-WKYs; 119 5 mmHg, P<0.001: 24W-SHRs; 177 14, 24W-WKYs; 141 12 mmHg, P<0.001) along with heart/body ratio (10W-SHRs; 4.1 0.3, 10W-WKYs; 3.3 0.4 mg/g, P<0.001: 24W-SHRs; 4.1 0.3, 24W-WKYs; 2.9 0.7 mg/g, P<0.01). Phosphorylation status of mTOR (129 10 vs 100 19 AU; P<0.01) and S6K (177 43 vs 100 33 AU; P<0.01) signifi cantly increased in 10W-SHRs versus 10W-WKYs in LA, but not in RA and also in 24W-rats. Immunohistochemistry revealed that non-cardiomyocytes including endothelial/endocardial cells and immunocytes were responsible for the increased phosphoryiation of S6K in 10W-SHRs. Discussion: These data show that mTOR regulates especially the early stage of atrial hypertrophy with hypertension, where non-cardiomyocytes are involved. Further studies into these signaling processes would clarify the unknown pathophysiology of atrial hypertrophy.
